Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-25-000979
Filing Date
2025-02-11
Accepted
2025-02-11 09:15:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5759
  Complete submission text file 0001085146-25-000979.txt   7564
Mailing Address ONE FINANCIAL CENTER 23RD FLOOR BOSTON MA 02111
Business Address ONE FINANCIAL CENTER 23RD FLOOR BOSTON MA 02111 6174287100
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by) CIK: 0001177719 (see all company filings)

EIN.: 800175963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Subject) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88586 | Film No.: 25607886
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)